Publications
2 shownErlotinib in Previously Treated Non–Small-Cell Lung Cancer
Erlotinib can prolong survival in patients with non-small-cell lung cancer after first-line or second-line chemotherapy.
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 7,391
- Institution
- Ontario Institute for Cancer Research
External Links
Identifiers
- ORCID
- 0000-0003-4842-2184
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.